• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Systemic and long term analysys of O2- hyperproduction mice

Research Project

Project/Area Number 24590393
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Pathological medical chemistry
Research InstitutionNippon Medical School

Principal Investigator

OKAMOTO Ken  日本医科大学, 医学部, 准教授 (60267143)

Co-Investigator(Kenkyū-buntansha) KUSANO Teruo  日本医科大学, 医学部, 助教 (30434129)
Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywordsキサンチン酸化還元酵素 / 活性酸素 / 虚血再灌流障害 / 抗痛風薬 / 全脳虚血 / キサンチン酸化酵素 / キサンチン脱水素酵素 / 脳虚血 / 一酸化窒素 / xanthine oxidase / xanthine dehydrogenase / repurfusion injury / brain ischemia / febuxostat
Outline of Final Research Achievements

Xanthine oxidoreductase (XOR) inhibitors are reported to protect tissues from damage caused by reactive oxygen species (ROS) by inhibiting its production through XOR inhibition. We analyzed the effects of inhibitors in decreasing global severe cerebral I/R damage in mice. Mice were divided into three groups: a placebo group, an allopurinol group, and a febuxostat group. Each groups was performed pathological examination on the CA1 and CA2 regions of the hippocampus 4 days after I/R surgery, which revealed that the number of neuronal cells decreased in the 14-min occlusion model in both regions but the drugs administered to prevent this damage were not effective. One of the reasons for the less effectiveness of XOR inhibitors to control severe whole brain ischemia in mouse model is due to the low levels of expression of XOR in the mouse brain.
We analyzed molecular mechanism of ROS production by XOR using C-terminal deleted mutant, and published the result as an original article.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • Research Products

    (9 results)

All 2015 2013 2012

All Journal Article (7 results) (of which Peer Reviewed: 7 results,  Open Access: 1 results) Book (2 results)

  • [Journal Article] The C-terminal Peptide Plays a Role in the Formation of an Intermediate Form during the Transition between Xanthine Dehydrogenase and Xanthine Oxidase2015

    • Author(s)
      Tomoko Nishino, Ken Okamoto, Yuko Kawaguchi, Tomohiro Matsumura, Bryan T. Eger, Emil F. Pai, Takeshi Nishino
    • Journal Title

      FEBS J

      Volume: Apr13 Issue: 16 Pages: 1-16

    • DOI

      10.1111/febs.13277

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Evaluation of Neuronal Protective Effects of Xanthine Oxidoreductase Inhibitors on Severe Whole-brain Ischemia in Mouse Model and Analysis of Xanthine Oxidoreductase Activity in the Mouse Brain2015

    • Author(s)
      Suzuki G, Okamoto , Kusano T, Matsuda Y, Fuse A, Yokota H.
    • Journal Title

      Neurologia medico-chirurgica

      Volume: 55 Issue: 1 Pages: 77-85

    • DOI

      10.2176/nmc.oa.2013-0307

    • NAID

      130004922260

    • ISSN
      0470-8105, 1349-8029
    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout.2015

    • Author(s)
      Nishino T, Okamoto K.
    • Journal Title

      J Biol Inorg Chem.

      Volume: 20 Issue: 2 Pages: 195-207

    • DOI

      10.1007/s00775-014-1210-x

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Chemical Nature and Reaction Mechanisms of the Molybdenum Cofactor of Xanthine Oxidoreductase.2013

    • Author(s)
      Okamoto K, Kusano K, Nishino T
    • Journal Title

      Curr Pharm Des

      Volume: 19 Pages: 2006-2014

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Role of N-glycosylation of human lysosomal phospholipase A2 for the formation of catalytically active enzyme.2013

    • Author(s)
      Hiraoka M, Okamoto K, Ohguro H, Abe A
    • Journal Title

      J Lipid Res

      Volume: 54 Issue: 11 Pages: 3098-3105

    • DOI

      10.1194/jlr.m041640

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Chemical Nature and Reaction Mechanisms of the Molybdenum Cofactor of Xanthine Oxidoreductase2013

    • Author(s)
      K. Okamoto, T. Kusano, T. Nishino.
    • Journal Title

      Curr. Pham. Des.

      Volume: 19 Issue: 14 Pages: 2606-2614

    • DOI

      10.2174/1381612811319140010

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans.2012

    • Author(s)
      Ichida K, Amaya Y, Okamoto K, Nishino T.
    • Journal Title

      Int J Mol Sci

      Volume: 13 Issue: 11 Pages: 15475-15495

    • DOI

      10.3390/ijms131115475

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Book] Hand book of flavoproteins Volume 22013

    • Author(s)
      Nishino T, Okamoto K, Eger B T, Pai E F
    • Total Pages
      22
    • Publisher
      de Gruyter, Germany
    • Related Report
      2013 Research-status Report
  • [Book] A new-generation uric acid production inhibitor: Febuxostat. in Analogue-based Drug Discovery III2012

    • Author(s)
      Okamoto K, Kondo S, Nishino T
    • Total Pages
      12
    • Publisher
      Wiley-VCH
    • Related Report
      2012 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi